research centers


Search results: Found 2

Listing 1 - 2 of 2
Sort by

Article
Determination of Serum Trace Elements and Hematological Parameters in Lymphoma Patients Receiving Chemotherapy

Authors: Zainab Hadi Kamil --- Mufeed Jalil Ewadh --- Abdulsamie Hassan Alta'ee
Journal: Journal of University of Babylon مجلة جامعة بابل ISSN: 19920652 23128135 Year: 2016 Volume: 24 Issue: 9 Pages: 2498-2509
Publisher: Babylon University جامعة بابل

Loading...
Loading...
Abstract

BackgroundTrace elements are essential components of biological structures, some of them play an important role as anticancer and others can be toxic at concentrations beyond those necessary for their biological functions.AimThe objective is to examine changes in serum concentration of trace elements (Cobalt (Co), Germanium (Ge), Molybdenum (Mo), Nickel (Ni) and Vanadium (V)), Mg and hematological changes in Hodgkin and Non-Hodgkin lymphoma patients receiving therapy.Materials and methodsThe study was included 25 patients with Non-Hodgkin lymphoma (NHL) and 25 patients with Hodgkin lymphoma (HL) as compared with 50 healthy subjects. Serum concentration of trace elements are measured by flame atomic absorption spectrophotometer. The total leukocyte count (TLC), hemoglobin concentration (Hb) and packed cell volume or hematocrit (Hct) are determined.Results Statistical analysis of data demonstrated significant decrease (p<0.001) in Mg and Co concentration and (p<0.01) in Ge concentration in patients with lymphomas receiving therapy as compared with healthy adults.V and Ni concentrations are significantly increased (p<0.001) in patients with lymphomas receiving therapy as compared with healthy adults. The study shows significant decrease (p<0.05) in Hb concentration and Hct percentage in patients with lymphomas receiving chemotherapy as compared with healthy subjects. It revealed significant decrease (p<0.005) in female patients with lymphoma who receive chemotherapy. Significant decrease (p<0.001) in TLC in patients with lymphomas receiving therapy as compared with healthy adults are observed. ConclusionLymphoma patients receiving therapy are often low in Mg, Ge and Co levels while Ni and V levels are high in patients with Hodgkin and Non-Hodgkin lymphoma.There is a significant decreased in TLC in patients with Hodgkin and Non-Hodgkin lymphoma whose are receiving chemotherapy..Anemia occurred in patient with lymphomas as a side effect of chemotherapy.

تعتبر العناصر النزرة مركبات أساسية في البناء الحيوي والبعض منها يلعب دوراَ مهماً كمضادات سرطانية والبعض الآخر يمكن ان يكون له تأثير سمي بالرغم من أهميته في الفعاليات الحيوية.الهدف من الدراسة معرفة التغيرات في تراكيز العناصر النزرة (الكوبالت (Co) ، الجرمانيوم (Ge) ، الموليبدينوم (Mo) ، والنيكل (Ni) و الفاناديوم (V) ) والمغنيسيوم (Mg) وكذلك التغيرات الدموية لدى مرضى سرطان الغدد اللمفاوية الهودجكني واللاهودجكني والمتلقين للعلاج الكيمياوي.شملت الدراسة 25 مريضاً بسرطان الغدد اللمفاوية الهودجكني و25 مريضاً بسرطان الغدد اللمفاوية اللاهودجكني مقارنة مع الاصحاء (50 شخصاً). تم قياس تراكيز العناصر النزرة في مصل الدم بجهاز المطياف (flame atomic absorption spectrophotometer) كما تم قياس تركيز الهيموكلوبين (Hb) ونسبة مكداس الدم (Hct) والعدد الكلي لخلايا الدم البيض (TLC).بين التحليل الاحصائي للعينات انخفاضاً معنوياً (p<0.001) في تركيز كل من Mg و Co وانخفاضاً معنوياً (p<0.01) في تركيز Ge لمرضى سرطان الغدد اللمفاوية لكلا النوعين والمتلقين للعلاج الكيمياوي مقارنة مع الاصحاء. كما ارتفع تركيز كل من Ni و V (p<0.001) لدى المرضى في هذه الدراسة.اظهرت الدراسة انخفاضاً معنوياً (p<0.05) في تركيز الهيموكلوبين ونسبة مكداس الدم وانخفاضاً معنوياً (p<0.001) في العد الكلي لخلايا الدم البيض لدى مرضى سرطان الغدد المفاوية والمتلقين للعلاج الكيمياوي مقارنةً مع الاصحاء.الاستنتاج: غالباً ما يكون تركيز كل من العناصر Mg و Ge و Co منخفضاً في مصل دم المرضى المصابين بسرطان الغدد اللمفاوية والمتلقين للعلاج الكيمياوي بينما يرتفع تركيز كل من Ni و V في مصلهم.حصول انخفاض معنوي في العدد الكلي خلايا الدم البيض لمرضى سرطان الغدد اللمفاوية والمتلقين للعلاج الكيمياوي كما يظهر لديهم فقر دم كعارض جانبي نتيجة للغلاج الكيمياوي.


Article
The Relationship between −330 Interleukin‑2 Gene Polymorphism and Its Plasma Levels in Patients with Alopecia Areata

Author: Sarah Isam Al‑Rubaye, Abdulsamie Hassan Alta’ee, Zena Saeed Al‑Fadhily
Journal: Medical Journal of Babylon مجلة بابل الطبية ISSN: 1812156X 23126760 Year: 2019 Volume: 16 Issue: 4 Pages: 292-295
Publisher: Babylon University جامعة بابل

Loading...
Loading...
Abstract

Background: Alopecia areata (AA) is an autoimmune, dermatological, chronic, inflammatory disease that attacks hair follicles and causeshair loss. Hair loss usually occurs on the scalp, but it can also affect the beard, eyebrows, and other areas of the body. Interleukin‑2 (IL‑2) isa cytokine that contributes to the regulation of the immune system and is classified as a proinflammatory factor. IL‑2 is an autocrine secretaryelement produced from activated T‑cells, exhibiting growth factor characteristics. Objective: The objective of this study was to investigatethe effect of the −330 IL‑2 gene polymorphism (rs2069762) on plasma IL‑2 levels in Iraqi patients with AA. Materials and Methods: Inthis study, 100 patients with AA and 100 ethnicity‑, age‑, and sex‑matched healthy controls were selected. Blood samples of all individualswere collected in EDTA tubes. The restriction fragment length polymorphism–polymerase chain reaction method was applied to determinevarious alleles and genotypes in these individuals. Plasma concentration of IL‑2 was measured in all the samples using human IL‑2 kit.Results: The frequency of −330 G/T IL‑2 genotype was higher in patients with AA compared to normal individuals. Accordingly, the plasmalevels of IL‑2 were significantly higher (P < 0.0090) in patients when compared to the control group. Conclusion: In case of patients withAA, the −330 G/T IL‑2 genotype is associated with higher plasma levels of IL‑2.

Listing 1 - 2 of 2
Sort by
Narrow your search

Resource type

article (2)


Language

English (2)


Year
From To Submit

2019 (1)

2016 (1)